Allergy Diagnostics Market By Test Type (In Vivo, In Vitro), By Product & Service (Consumables, Instruments, Services), By Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), By End-user (Diagnostic Laboratories, Hospital-based
Description
Allergy Diagnostics Market By Test Type (In Vivo, In Vitro), By Product & Service (Consumables, Instruments, Services), By Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), By End-user (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global allergy diagnostic market is envisioned to garner $16,714.2 million by 2031, growing from $4,965.4 million in 2021 at a CAGR of 13.2% from 2022 to 2031.
An allergy is referred to as a systemic sensitivity condition in medical terminology. To assess whether the patient's body is allergic to any known substances, a competent allergy expert will perform an allergy diagnostic test. The diagnosis of allergy is typically made with a diagnostic test or a biopsy.
The main risk factors for developing chronic respiratory disorders are occupational exposure, allergen exposure, and exposure to indoor and outdoor air pollution. Due to the greater exposure to environmental toxins in cities, the prevalence of allergy illnesses is higher among urban residents than rural residents (as a result of vehicular pollution and industrial activities). Although this is a worldwide trend, its impacts are more severe in the metropolitan regions of low-income nations, where more than 80% of people live in locations where air quality levels exceed WHO (World Health Organization) safety guidelines. Given that air pollution from automobiles has been identified as one of the key risk factors contributing to allergic disorders, this is a significant signal for the market growth for allergy diagnostic. Asthma, allergic rhinitis, and other allergy illnesses are more common when there is air pollution, according to epidemiological and toxicological study. Studies have also shown a considerable rise in the prevalence and severity of asthma attacks in metropolitan areas with high concentrations of ozone, nitrogen dioxide, and PM 2.5 (particulate matter having a diameter of 2.5 micrometers or smaller). Members of the allergy and immunology communities have conducted studies that demonstrate how pollutants enhance early and late allergic reactions.
On the other side, it is also anticipated that the rising price of allergy diagnostic equipment would restrain the market expansion over the projected time frame. The shortage of allergists, however, may provide further difficulties for the development of the allergy diagnostic industry in the near future.
The market for allergy diagnostic is predicted to have lucrative opportunities due to the growing adoption of mHealth apps. The use of mHealth for rhinitis diagnosis is currently restricted since there are so few mHealth tools for Allergic Rhinitis (AR) diagnosis that have been published in peer-reviewed publications. Recent developments in integrated biosensors, wireless connectivity, and power harvesting methods have given rise to a new generation of point-of-care gadgets.
Due to the global COVID outbreak, there was a little reduction in the market for allergy diagnostics. Given that affected patients are well-instructed about avoiding potential environmental triggers and treating acute events, also based on written action plans, diagnostic procedures were postponed in the majority of allergic diseases. However, once the pandemic was under control, the diagnostic processes resumed.
The key players profiled in this report include Thermo Fisher Scientific, PerkinElmer Inc., Danaher, Hitachi Chemicals, BIOMÉRIEUX, Omega Diagnostics Group PLC, Siemens, Eurofins Scientific, Stallergenes Greer, and Neogen Corporation
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the allergy diagnostic market analysis from 2021 to 2031 to identify the prevailing allergy diagnostic market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the allergy diagnostic market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global allergy diagnostic market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Test Type
In Vitro
In Vivo
By Product Service
Consumables
Instruments
Services
By Allergen
Inhaled Allergens
Food Allergens
Drug Allergens
Other Allergens
By End-user
Diagnostic Laboratories
Hospital-based Laboratories
Academic Research Institutes
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
United Arab Emirates
South Africa
Rest of LAMEA
Key Market Players
Alerchek Inc.
Danaher Corp
Hitachi chemical Diagnostic Inc.
HOB Biotech Group Co. Ltd.
Hycor Biomedical Inc.
Lincoln Diagnostics Inc.
Omega Diagnostic Llc
Siemens Healthcare Diagnostics, Inc.
Stallergenes SA
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
Danaher
Omega Diagnostics Group PLC
Eurofins Scientific
bioMérieux SA
HollisterStier Allergy
Minaris Medical America, Inc.
ACON Laboratories, Inc.
Lincoln Diagnostics, Inc.
Neogen Corporation
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
The global allergy diagnostic market is envisioned to garner $16,714.2 million by 2031, growing from $4,965.4 million in 2021 at a CAGR of 13.2% from 2022 to 2031.
An allergy is referred to as a systemic sensitivity condition in medical terminology. To assess whether the patient's body is allergic to any known substances, a competent allergy expert will perform an allergy diagnostic test. The diagnosis of allergy is typically made with a diagnostic test or a biopsy.
The main risk factors for developing chronic respiratory disorders are occupational exposure, allergen exposure, and exposure to indoor and outdoor air pollution. Due to the greater exposure to environmental toxins in cities, the prevalence of allergy illnesses is higher among urban residents than rural residents (as a result of vehicular pollution and industrial activities). Although this is a worldwide trend, its impacts are more severe in the metropolitan regions of low-income nations, where more than 80% of people live in locations where air quality levels exceed WHO (World Health Organization) safety guidelines. Given that air pollution from automobiles has been identified as one of the key risk factors contributing to allergic disorders, this is a significant signal for the market growth for allergy diagnostic. Asthma, allergic rhinitis, and other allergy illnesses are more common when there is air pollution, according to epidemiological and toxicological study. Studies have also shown a considerable rise in the prevalence and severity of asthma attacks in metropolitan areas with high concentrations of ozone, nitrogen dioxide, and PM 2.5 (particulate matter having a diameter of 2.5 micrometers or smaller). Members of the allergy and immunology communities have conducted studies that demonstrate how pollutants enhance early and late allergic reactions.
On the other side, it is also anticipated that the rising price of allergy diagnostic equipment would restrain the market expansion over the projected time frame. The shortage of allergists, however, may provide further difficulties for the development of the allergy diagnostic industry in the near future.
The market for allergy diagnostic is predicted to have lucrative opportunities due to the growing adoption of mHealth apps. The use of mHealth for rhinitis diagnosis is currently restricted since there are so few mHealth tools for Allergic Rhinitis (AR) diagnosis that have been published in peer-reviewed publications. Recent developments in integrated biosensors, wireless connectivity, and power harvesting methods have given rise to a new generation of point-of-care gadgets.
Due to the global COVID outbreak, there was a little reduction in the market for allergy diagnostics. Given that affected patients are well-instructed about avoiding potential environmental triggers and treating acute events, also based on written action plans, diagnostic procedures were postponed in the majority of allergic diseases. However, once the pandemic was under control, the diagnostic processes resumed.
The key players profiled in this report include Thermo Fisher Scientific, PerkinElmer Inc., Danaher, Hitachi Chemicals, BIOMÉRIEUX, Omega Diagnostics Group PLC, Siemens, Eurofins Scientific, Stallergenes Greer, and Neogen Corporation
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the allergy diagnostic market analysis from 2021 to 2031 to identify the prevailing allergy diagnostic market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the allergy diagnostic market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global allergy diagnostic market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Test Type
In Vitro
In Vivo
By Product Service
Consumables
Instruments
Services
By Allergen
Inhaled Allergens
Food Allergens
Drug Allergens
Other Allergens
By End-user
Diagnostic Laboratories
Hospital-based Laboratories
Academic Research Institutes
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
United Arab Emirates
South Africa
Rest of LAMEA
Key Market Players
Alerchek Inc.
Danaher Corp
Hitachi chemical Diagnostic Inc.
HOB Biotech Group Co. Ltd.
Hycor Biomedical Inc.
Lincoln Diagnostics Inc.
Omega Diagnostic Llc
Siemens Healthcare Diagnostics, Inc.
Stallergenes SA
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
Danaher
Omega Diagnostics Group PLC
Eurofins Scientific
bioMérieux SA
HollisterStier Allergy
Minaris Medical America, Inc.
ACON Laboratories, Inc.
Lincoln Diagnostics, Inc.
Neogen Corporation
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Table of Contents
390 Pages
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- 3.7.Value Chain Analysis
- 3.8.Regulatory Guidelines
- 3.9.Market Share Analysis
- 3.10.Key Regulation Analysis
- 3.11.Patent Landscape
- CHAPTER 4: WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 In Vivo
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 In Vitro
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- CHAPTER 5: WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Consumables
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Instruments
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Services
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Inhaled Allergens
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Food Allergens
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Drug Allergens
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- 6.5 Other Allergens
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
- CHAPTER 7: WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Diagnostic Laboratories
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
- 7.3 Hospital-based Laboratories
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
- 7.4 Academic Research Institutes
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
- 7.5 Others
- 7.5.1 Key market trends, growth factors and opportunities
- 7.5.2 Market size and forecast, by region
- 7.5.3 Market analysis by country
- CHAPTER 8: WORLD ALLERGY DIAGNOSTIC MARKET, BY REGION
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Test Type
- 8.2.3 North America Market size and forecast, by Product & Service
- 8.2.4 North America Market size and forecast, by Allergen
- 8.2.5 North America Market size and forecast, by End-user
- 8.2.6 North America Market size and forecast, by country
- 8.2.6.1 U.S.
- 8.2.6.1.1 Market size and forecast, by Test Type
- 8.2.6.1.2 Market size and forecast, by Product & Service
- 8.2.6.1.3 Market size and forecast, by Allergen
- 8.2.6.1.4 Market size and forecast, by End-user
- 8.2.6.2 Canada
- 8.2.6.2.1 Market size and forecast, by Test Type
- 8.2.6.2.2 Market size and forecast, by Product & Service
- 8.2.6.2.3 Market size and forecast, by Allergen
- 8.2.6.2.4 Market size and forecast, by End-user
- 8.2.6.3 Mexico
- 8.2.6.3.1 Market size and forecast, by Test Type
- 8.2.6.3.2 Market size and forecast, by Product & Service
- 8.2.6.3.3 Market size and forecast, by Allergen
- 8.2.6.3.4 Market size and forecast, by End-user
- 8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Test Type
- 8.3.3 Europe Market size and forecast, by Product & Service
- 8.3.4 Europe Market size and forecast, by Allergen
- 8.3.5 Europe Market size and forecast, by End-user
- 8.3.6 Europe Market size and forecast, by country
- 8.3.6.1 Germany
- 8.3.6.1.1 Market size and forecast, by Test Type
- 8.3.6.1.2 Market size and forecast, by Product & Service
- 8.3.6.1.3 Market size and forecast, by Allergen
- 8.3.6.1.4 Market size and forecast, by End-user
- 8.3.6.2 UK
- 8.3.6.2.1 Market size and forecast, by Test Type
- 8.3.6.2.2 Market size and forecast, by Product & Service
- 8.3.6.2.3 Market size and forecast, by Allergen
- 8.3.6.2.4 Market size and forecast, by End-user
- 8.3.6.3 France
- 8.3.6.3.1 Market size and forecast, by Test Type
- 8.3.6.3.2 Market size and forecast, by Product & Service
- 8.3.6.3.3 Market size and forecast, by Allergen
- 8.3.6.3.4 Market size and forecast, by End-user
- 8.3.6.4 Spain
- 8.3.6.4.1 Market size and forecast, by Test Type
- 8.3.6.4.2 Market size and forecast, by Product & Service
- 8.3.6.4.3 Market size and forecast, by Allergen
- 8.3.6.4.4 Market size and forecast, by End-user
- 8.3.6.5 Italy
- 8.3.6.5.1 Market size and forecast, by Test Type
- 8.3.6.5.2 Market size and forecast, by Product & Service
- 8.3.6.5.3 Market size and forecast, by Allergen
- 8.3.6.5.4 Market size and forecast, by End-user
- 8.3.6.6 Rest of Europe
- 8.3.6.6.1 Market size and forecast, by Test Type
- 8.3.6.6.2 Market size and forecast, by Product & Service
- 8.3.6.6.3 Market size and forecast, by Allergen
- 8.3.6.6.4 Market size and forecast, by End-user
- 8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Test Type
- 8.4.3 Asia-Pacific Market size and forecast, by Product & Service
- 8.4.4 Asia-Pacific Market size and forecast, by Allergen
- 8.4.5 Asia-Pacific Market size and forecast, by End-user
- 8.4.6 Asia-Pacific Market size and forecast, by country
- 8.4.6.1 China
- 8.4.6.1.1 Market size and forecast, by Test Type
- 8.4.6.1.2 Market size and forecast, by Product & Service
- 8.4.6.1.3 Market size and forecast, by Allergen
- 8.4.6.1.4 Market size and forecast, by End-user
- 8.4.6.2 Japan
- 8.4.6.2.1 Market size and forecast, by Test Type
- 8.4.6.2.2 Market size and forecast, by Product & Service
- 8.4.6.2.3 Market size and forecast, by Allergen
- 8.4.6.2.4 Market size and forecast, by End-user
- 8.4.6.3 India
- 8.4.6.3.1 Market size and forecast, by Test Type
- 8.4.6.3.2 Market size and forecast, by Product & Service
- 8.4.6.3.3 Market size and forecast, by Allergen
- 8.4.6.3.4 Market size and forecast, by End-user
- 8.4.6.4 South Korea
- 8.4.6.4.1 Market size and forecast, by Test Type
- 8.4.6.4.2 Market size and forecast, by Product & Service
- 8.4.6.4.3 Market size and forecast, by Allergen
- 8.4.6.4.4 Market size and forecast, by End-user
- 8.4.6.5 Australia
- 8.4.6.5.1 Market size and forecast, by Test Type
- 8.4.6.5.2 Market size and forecast, by Product & Service
- 8.4.6.5.3 Market size and forecast, by Allergen
- 8.4.6.5.4 Market size and forecast, by End-user
- 8.4.6.6 Rest of Asia-Pacific
- 8.4.6.6.1 Market size and forecast, by Test Type
- 8.4.6.6.2 Market size and forecast, by Product & Service
- 8.4.6.6.3 Market size and forecast, by Allergen
- 8.4.6.6.4 Market size and forecast, by End-user
- 8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Test Type
- 8.5.3 LAMEA Market size and forecast, by Product & Service
- 8.5.4 LAMEA Market size and forecast, by Allergen
- 8.5.5 LAMEA Market size and forecast, by End-user
- 8.5.6 LAMEA Market size and forecast, by country
- 8.5.6.1 Brazil
- 8.5.6.1.1 Market size and forecast, by Test Type
- 8.5.6.1.2 Market size and forecast, by Product & Service
- 8.5.6.1.3 Market size and forecast, by Allergen
- 8.5.6.1.4 Market size and forecast, by End-user
- 8.5.6.2 Saudi Arabia
- 8.5.6.2.1 Market size and forecast, by Test Type
- 8.5.6.2.2 Market size and forecast, by Product & Service
- 8.5.6.2.3 Market size and forecast, by Allergen
- 8.5.6.2.4 Market size and forecast, by End-user
- 8.5.6.3 United Arab Emirates
- 8.5.6.3.1 Market size and forecast, by Test Type
- 8.5.6.3.2 Market size and forecast, by Product & Service
- 8.5.6.3.3 Market size and forecast, by Allergen
- 8.5.6.3.4 Market size and forecast, by End-user
- 8.5.6.4 South Africa
- 8.5.6.4.1 Market size and forecast, by Test Type
- 8.5.6.4.2 Market size and forecast, by Product & Service
- 8.5.6.4.3 Market size and forecast, by Allergen
- 8.5.6.4.4 Market size and forecast, by End-user
- 8.5.6.5 Rest of LAMEA
- 8.5.6.5.1 Market size and forecast, by Test Type
- 8.5.6.5.2 Market size and forecast, by Product & Service
- 8.5.6.5.3 Market size and forecast, by Allergen
- 8.5.6.5.4 Market size and forecast, by End-user
- CHAPTER 9: COMPANY LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Key developments
- CHAPTER 10: COMPANY PROFILES
- 10.1 Alerchek Inc.
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
- 10.2 Danaher Corp
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
- 10.3 Hitachi chemical Diagnostic Inc.
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
- 10.4 HOB Biotech Group Co. Ltd.
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
- 10.5 Hycor Biomedical Inc.
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
- 10.6 Lincoln Diagnostics Inc.
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
- 10.7 Omega Diagnostic Llc
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
- 10.8 Siemens Healthcare Diagnostics, Inc.
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
- 10.9 Stallergenes SA
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
- 10.10 Thermo Fisher Scientific Inc.
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments
- 10.11 Thermo Fisher Scientific Inc.
- 10.11.1 Company overview
- 10.11.2 Company snapshot
- 10.11.3 Operating business segments
- 10.11.4 Product portfolio
- 10.11.5 Business performance
- 10.11.6 Key strategic moves and developments
- 10.12 Danaher
- 10.12.1 Company overview
- 10.12.2 Company snapshot
- 10.12.3 Operating business segments
- 10.12.4 Product portfolio
- 10.12.5 Business performance
- 10.12.6 Key strategic moves and developments
- 10.13 Omega Diagnostics Group PLC
- 10.13.1 Company overview
- 10.13.2 Company snapshot
- 10.13.3 Operating business segments
- 10.13.4 Product portfolio
- 10.13.5 Business performance
- 10.13.6 Key strategic moves and developments
- 10.14 Eurofins Scientific
- 10.14.1 Company overview
- 10.14.2 Company snapshot
- 10.14.3 Operating business segments
- 10.14.4 Product portfolio
- 10.14.5 Business performance
- 10.14.6 Key strategic moves and developments
- 10.15 bioMérieux SA
- 10.15.1 Company overview
- 10.15.2 Company snapshot
- 10.15.3 Operating business segments
- 10.15.4 Product portfolio
- 10.15.5 Business performance
- 10.15.6 Key strategic moves and developments
- 10.16 HollisterStier Allergy
- 10.16.1 Company overview
- 10.16.2 Company snapshot
- 10.16.3 Operating business segments
- 10.16.4 Product portfolio
- 10.16.5 Business performance
- 10.16.6 Key strategic moves and developments
- 10.17 Minaris Medical America, Inc.
- 10.17.1 Company overview
- 10.17.2 Company snapshot
- 10.17.3 Operating business segments
- 10.17.4 Product portfolio
- 10.17.5 Business performance
- 10.17.6 Key strategic moves and developments
- 10.18 ACON Laboratories, Inc.
- 10.18.1 Company overview
- 10.18.2 Company snapshot
- 10.18.3 Operating business segments
- 10.18.4 Product portfolio
- 10.18.5 Business performance
- 10.18.6 Key strategic moves and developments
- 10.19 Lincoln Diagnostics, Inc.
- 10.19.1 Company overview
- 10.19.2 Company snapshot
- 10.19.3 Operating business segments
- 10.19.4 Product portfolio
- 10.19.5 Business performance
- 10.19.6 Key strategic moves and developments
- 10.20 Neogen Corporation
- 10.20.1 Company overview
- 10.20.2 Company snapshot
- 10.20.3 Operating business segments
- 10.20.4 Product portfolio
- 10.20.5 Business performance
- 10.20.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 2. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR IN VIVO, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. WORLD ALLERGY DIAGNOSTIC MARKET FOR IN VIVO, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR IN VITRO, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. WORLD ALLERGY DIAGNOSTIC MARKET FOR IN VITRO, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. GLOBAL WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 7. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
- TABLE 8. WORLD ALLERGY DIAGNOSTIC MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 9. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. WORLD ALLERGY DIAGNOSTIC MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. WORLD ALLERGY DIAGNOSTIC MARKET FOR SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 13. GLOBAL WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 14. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR INHALED ALLERGENS, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. WORLD ALLERGY DIAGNOSTIC MARKET FOR INHALED ALLERGENS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR FOOD ALLERGENS, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. WORLD ALLERGY DIAGNOSTIC MARKET FOR FOOD ALLERGENS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR DRUG ALLERGENS, BY REGION, 2021-2031 ($MILLION)
- TABLE 19. WORLD ALLERGY DIAGNOSTIC MARKET FOR DRUG ALLERGENS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 20. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR OTHER ALLERGENS, BY REGION, 2021-2031 ($MILLION)
- TABLE 21. WORLD ALLERGY DIAGNOSTIC MARKET FOR OTHER ALLERGENS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 22. GLOBAL WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 23. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 24. WORLD ALLERGY DIAGNOSTIC MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 25. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 26. WORLD ALLERGY DIAGNOSTIC MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 27. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION)
- TABLE 28. WORLD ALLERGY DIAGNOSTIC MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 29. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 30. WORLD ALLERGY DIAGNOSTIC MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 31. WORLD ALLERGY DIAGNOSTIC MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 32. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 33. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 34. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 35. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 36. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 37. U.S. WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 38. U.S. WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 39. U.S. WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 40. U.S. WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 41. CANADA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 42. CANADA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 43. CANADA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 44. CANADA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 45. MEXICO WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 46. MEXICO WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 47. MEXICO WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 48. MEXICO WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 49. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 50. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 51. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 52. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 53. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 54. GERMANY WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 55. GERMANY WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 56. GERMANY WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 57. GERMANY WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 58. UK WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 59. UK WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 60. UK WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 61. UK WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 62. FRANCE WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 63. FRANCE WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 64. FRANCE WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 65. FRANCE WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 66. SPAIN WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 67. SPAIN WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 68. SPAIN WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 69. SPAIN WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 70. ITALY WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 71. ITALY WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 72. ITALY WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 73. ITALY WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 74. REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 75. REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 76. REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 77. REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 78. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 79. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 80. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 81. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 82. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 83. CHINA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 84. CHINA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 85. CHINA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 86. CHINA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 87. JAPAN WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 88. JAPAN WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 89. JAPAN WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 90. JAPAN WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 91. INDIA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 92. INDIA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 93. INDIA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 94. INDIA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 95. SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 96. SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 97. SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 98. SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 99. AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 100. AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 101. AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 102. AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 103. REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 104. REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 105. REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 106. REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 107. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 108. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 109. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 110. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 111. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 112. BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 113. BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 114. BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 115. BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 116. SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 117. SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 118. SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 119. SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 120. UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 121. UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 122. UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 123. UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 124. SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 125. SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 126. SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 127. SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 128. REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
- TABLE 129. REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
- TABLE 130. REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
- TABLE 131. REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 132.ALERCHEK INC.: COMPANY SNAPSHOT
- TABLE 133.ALERCHEK INC.: OPERATING SEGMENTS
- TABLE 134.ALERCHEK INC.: PRODUCT PORTFOLIO
- TABLE 135.ALERCHEK INC.: NET SALES,
- TABLE 136.ALERCHEK INC.: KEY STRATERGIES
- TABLE 137.DANAHER CORP: COMPANY SNAPSHOT
- TABLE 138.DANAHER CORP: OPERATING SEGMENTS
- TABLE 139.DANAHER CORP: PRODUCT PORTFOLIO
- TABLE 140.DANAHER CORP: NET SALES,
- TABLE 141.DANAHER CORP: KEY STRATERGIES
- TABLE 142.HITACHI CHEMICAL DIAGNOSTIC INC.: COMPANY SNAPSHOT
- TABLE 143.HITACHI CHEMICAL DIAGNOSTIC INC.: OPERATING SEGMENTS
- TABLE 144.HITACHI CHEMICAL DIAGNOSTIC INC.: PRODUCT PORTFOLIO
- TABLE 145.HITACHI CHEMICAL DIAGNOSTIC INC.: NET SALES,
- TABLE 146.HITACHI CHEMICAL DIAGNOSTIC INC.: KEY STRATERGIES
- TABLE 147.HOB BIOTECH GROUP CO. LTD.: COMPANY SNAPSHOT
- TABLE 148.HOB BIOTECH GROUP CO. LTD.: OPERATING SEGMENTS
- TABLE 149.HOB BIOTECH GROUP CO. LTD.: PRODUCT PORTFOLIO
- TABLE 150.HOB BIOTECH GROUP CO. LTD.: NET SALES,
- TABLE 151.HOB BIOTECH GROUP CO. LTD.: KEY STRATERGIES
- TABLE 152.HYCOR BIOMEDICAL INC.: COMPANY SNAPSHOT
- TABLE 153.HYCOR BIOMEDICAL INC.: OPERATING SEGMENTS
- TABLE 154.HYCOR BIOMEDICAL INC.: PRODUCT PORTFOLIO
- TABLE 155.HYCOR BIOMEDICAL INC.: NET SALES,
- TABLE 156.HYCOR BIOMEDICAL INC.: KEY STRATERGIES
- TABLE 157.LINCOLN DIAGNOSTICS INC.: COMPANY SNAPSHOT
- TABLE 158.LINCOLN DIAGNOSTICS INC.: OPERATING SEGMENTS
- TABLE 159.LINCOLN DIAGNOSTICS INC.: PRODUCT PORTFOLIO
- TABLE 160.LINCOLN DIAGNOSTICS INC.: NET SALES,
- TABLE 161.LINCOLN DIAGNOSTICS INC.: KEY STRATERGIES
- TABLE 162.OMEGA DIAGNOSTIC LLC: COMPANY SNAPSHOT
- TABLE 163.OMEGA DIAGNOSTIC LLC: OPERATING SEGMENTS
- TABLE 164.OMEGA DIAGNOSTIC LLC: PRODUCT PORTFOLIO
- TABLE 165.OMEGA DIAGNOSTIC LLC: NET SALES,
- TABLE 166.OMEGA DIAGNOSTIC LLC: KEY STRATERGIES
- TABLE 167.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: COMPANY SNAPSHOT
- TABLE 168.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: OPERATING SEGMENTS
- TABLE 169.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
- TABLE 170.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: NET SALES,
- TABLE 171.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: KEY STRATERGIES
- TABLE 172.STALLERGENES SA: COMPANY SNAPSHOT
- TABLE 173.STALLERGENES SA: OPERATING SEGMENTS
- TABLE 174.STALLERGENES SA: PRODUCT PORTFOLIO
- TABLE 175.STALLERGENES SA: NET SALES,
- TABLE 176.STALLERGENES SA: KEY STRATERGIES
- TABLE 177.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
- TABLE 178.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
- TABLE 179.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
- TABLE 180.THERMO FISHER SCIENTIFIC INC.: NET SALES,
- TABLE 181.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
- TABLE 182.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
- TABLE 183.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
- TABLE 184.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
- TABLE 185.THERMO FISHER SCIENTIFIC INC.: NET SALES,
- TABLE 186.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
- TABLE 187.DANAHER: COMPANY SNAPSHOT
- TABLE 188.DANAHER: OPERATING SEGMENTS
- TABLE 189.DANAHER: PRODUCT PORTFOLIO
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
